HIGHLIGHTS
- who: Miguel Jimu00e9nez-Pu00e9rez and colleagues from the Department of Gastroenterology and Hepatology, Unit, University Hospital Carlos Haya, Mu00e1laga, Spain have published the paper: Post-transplant plasma cell hepatitis in a liver transplant patient treated with pegylated interferon plus ribavirin, in the Journal: (JOURNAL)
- what: The authors report the case of a transplant patient who received treatment with PEG-INF/RBV and developed plasma cell as the presenting form of rejection.
SUMMARY
Because of its form of presentation and the existence of histological features that are superimposed on other entities, such . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.